The store will not work correctly when cookies are disabled.
4,6-Bis(benzylthio)-2-(methylthio)pyrimidine-5-carboxylic Acid
ID: ALA1172425
Cas Number: 883872-01-3
PubChem CID: 16040328
Max Phase: Preclinical
Molecular Formula: C20H18N2O2S3
Molecular Weight: 414.58
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CSc1nc(SCc2ccccc2)c(C(=O)O)c(SCc2ccccc2)n1
Standard InChI: InChI=1S/C20H18N2O2S3/c1-25-20-21-17(26-12-14-8-4-2-5-9-14)16(19(23)24)18(22-20)27-13-15-10-6-3-7-11-15/h2-11H,12-13H2,1H3,(H,23,24)
Standard InChI Key: JQFMWAZMMYZMOM-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
1.9432 -8.3395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6576 -8.7520 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.6576 -9.5770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9432 -9.9895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2287 -9.5770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2287 -8.7520 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.9432 -10.8145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2287 -11.2270 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.6576 -11.2270 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.9432 -7.5145 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.2287 -7.1020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5142 -9.9895 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-0.2003 -9.5770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9147 -9.9895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9147 -10.8145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6292 -11.2270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3437 -10.8145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3437 -9.9895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6292 -9.5770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3721 -9.9895 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.0866 -9.5770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8010 -9.9895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5155 -9.5770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2300 -9.9895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2300 -10.8145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5155 -11.2270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8010 -10.8145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
1 6 2 0
7 8 2 0
7 9 1 0
4 7 1 0
10 11 1 0
1 10 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
14 19 2 0
12 13 1 0
5 12 1 0
21 22 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
22 27 2 0
20 21 1 0
3 20 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 414.58 | Molecular Weight (Monoisotopic): 414.0530 | AlogP: 5.48 | #Rotatable Bonds: 8 |
Polar Surface Area: 63.08 | Molecular Species: ACID | HBA: 6 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 3.70 | CX Basic pKa: 0.62 | CX LogP: 6.70 | CX LogD: 3.39 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.30 | Np Likeness Score: -0.93 |
References
1. Seto S, Okada K, Kiyota K, Isogai S, Iwago M, Shinozaki T, Kitamura Y, Kohno Y, Murakami K.. (2010) Design, synthesis, and structure-activity relationship studies of novel 2,4,6-trisubstituted-5-pyrimidinecarboxylic acids as peroxisome proliferator-activated receptor gamma (PPARgamma) partial agonists with comparable antidiabetic efficacy to rosiglitazone., 53 (13): [PMID:20527969] [10.1021/jm100443s] |